p53 tumor supressor protein
Showing 1 - 25 of >10,000
Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib plus RCHOP
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023
Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)
Recruiting
- Locally Advanced Cervical Cancer
- Curcumin
- Curcumin + Piperine
-
Mexico City, MexicoInstituto Nacional de Cancerología
Oct 6, 2023
p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome
Completed
- Mitochondrial Disorders
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 18, 2021
Endometrial Cancer, Serous Tumor, P53 Mutation Trial in Toronto (Cisplatin, External Beam Radiation, Carboplatin)
Recruiting
- Endometrial Cancer
- +2 more
- Cisplatin
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 20, 2021
Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)
Recruiting
- Pancreas Cancer
- +3 more
- Modified GCN+TTF treatment
-
Jacksonville, FloridaMayo Clinic
Apr 4, 2022
Prognostic Prediction Based on Radiomics of Giant Cell Tumor of
Completed
- Spinal Tumor
- RANK/RANKL(RANK: Receptor Activator of Nuclear factor Kappa-Β /RANKL:Receptor Activator of Nuclear factor Kappa-Β Ligand)
-
Beijing, Please Select An Option Below, ChinaPeking University third hospital
Jun 28, 2021
Psoriasis Trial in Irvine, Winston-Salem, Seattle (Etanercept, Placebo injections)
Completed
- Psoriasis
- Etanercept
- Placebo injections
-
Irvine, California
- +2 more
Jun 10, 2021
Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)
Unknown status
- Wilms Tumor
- +2 more
- P53, Ki67 and Cyclin A IHC.
-
Mansoura, Dakahlia, EgyptMansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021
HER2-positive Breast Cancer, HER2 Low, SYD-985 Trial in Aurora (Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)
Recruiting
- HER2-positive Breast Cancer
- +26 more
- Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Oct 22, 2021
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Metastatic Solid Tumor Cancer, Recurrent Head Neck Cancer Trial in Houston (Ad-P53, Xeloda, Keytruda)
Terminated
- Metastatic Solid Tumor Cancer
- Recurrent Head and Neck Cancer
- Ad-P53
- +3 more
-
Houston, TexasMD Anderson Cancer Center
May 30, 2020
Head and Neck Squamous Cell Carcinoma Trial in New Haven (5-Azacitadine)
Completed
- Head and Neck Squamous Cell Carcinoma
-
New Haven, ConnecticutSmilow Cancer Center at Yale New Haven Hospital
Feb 3, 2022
Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)
Not yet recruiting
- Pediatric Cancer
- +2 more
- Arsenic trioxide
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023
Barrett's Oesophagus Trial in Cambridge (Cytosponge test, Assessment of the panel of molecular biomarkers: IM-SCORE, TFF3
Recruiting
- Barrett's Oesophagus
- Cytosponge test
- +2 more
-
Cambridge, United KingdomMRC Cancer Unit
Nov 3, 2020
Head and Neck Tumors, Quality of Life, Nutrition Related Cancer Trial in Thailand (Nutri-jelly with PEITC, Nutri-jelly)
Active, not recruiting
- Head and Neck Neoplasms
- +2 more
- Nutri-jelly with PEITC
- Nutri-jelly
-
Bankok, Bangkok, Thailand
- +4 more
Oct 6, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
SNPs in p53 and p53 Response Elements on Inflammatory Response
Completed
- HIV-1 Seropositive
- +3 more
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 21, 2023
Unusual Infiltrative Patterns of Malignant Cells in Endometrial
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 11, 2023
Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)
Recruiting
- Endometrial Cancer
- Selinexor
- Matching Placebo for selinexor
-
Miami Beach, Florida
- +6 more
Jan 31, 2023